Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine

European Neuropsychopharmacology

Volumn 14, Issue 4, 2004, Pages 324-331

  Alttoa, Aet ^a   Harro, Jaanus ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Amphetamine; CCK; Devazepide; Exploratory behavior; L 365,260; Sensitization

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; AMPHETAMINE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; DEVAZEPIDE; BENZODIAZEPINE DERIVATIVE; CARBANILAMIDE DERIVATIVE; CENTRAL STIMULANT AGENT; CHOLECYSTOKININ RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SENSITIZATION; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG INTERACTION; MOTOR ACTIVITY; WISTAR RAT;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; BENZODIAZEPINONES; CENTRAL NERVOUS SYSTEM STIMULANTS; DEVAZEPIDE; DRUG INTERACTIONS; EXPLORATORY BEHAVIOR; MALE; MOTOR ACTIVITY; PHENYLUREA COMPOUNDS; RATS; RATS, WISTAR; RECEPTORS, CHOLECYSTOKININ;

EID: 2442466637     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2003.09.006     Document Type: Article

References (43)

1. Badiani A., Oates M.M., Fraioli S., Browman K.E., Ostrander M.M., Xue C.J., Wolf M.E., Robinson T.E. Environmental modulation of the response to amphetamine: dissociation between changes in behavior and changes in dopamine and glutamate overflow in the rat striatal complex. Psychopharmacology (Berlin). 151:2000;166-174
2. Beinfeld M.C., Connolly K., Pierce R.C. OLETF (Otsuka Long-Evans Tokushima Fatty) rats that lack the CCK 1 (A) receptor develop less behavioral sensitization to repeated cocaine treatment than wild type LETO (Long Evans Tokushima Otsuka) rats. Peptides. 22:2001;1285-1290
3. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res. Rev. 28:1998;309-369
4. Blacker D., Broberger C., Ögren S.-O., Hökfelt T. Cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-D-aspartate antagonists phencyclidine and dizocilpine maleate. Neuroscience. 76:1997;1057-1067
5. Bourin M., Malinge M., Vasar E., Bradwejn J. Two faces of cholecystokinin: anxiety and schizophrenia. Fundam. Clin. Pharmacol. 10:1996;116-126
6. Crawley J.N. Cholecystokinin-dopamine interactions. Trends Pharmacol. Sci. 12:1991;232-236
7. Crawley J.N. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway. J. Neurosci. 12:1992;3380-3391
8. Crawley J.N. Cholecystokinin modulates dopamine-mediated behaviors. Differential actions in medial posterior versus anterior nucleus accumbens. Ann. New York Acad. Sci. 713:1994;138-142
9. Crawley J.N., Corwin R.L. Biological actions of cholecystokinin. Peptides. 15:1994;731-755
10. Dauge V., Beslot F., Matsui T., Roques B.P. Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine. Neurosci. Lett. 306:2001;41-44
11. Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: a review and conceptualization. Am. J. Psychiatry. 148:1991;1474-1486
12. A receptors. Pharmacol. Biochem. Behav. 62:1999;31-37
13. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278
14. Feifel D., Priebe K., Shilling P.D. Startle and sensorimotor gating in rats lacking CCK-A receptors. Neuropsychopharmacology. 24:2001;663-670
15. B receptors mediate the regulation of exploratory behaviour in the rat. Eur. J. Pharmacol. 193:1991;379-381
16. Harro J., Vasar E., Bradwejn J. Cholecystokinin in animal and human research on anxiety. Trends Pharmacol. Sci. 14:1993;244-249
17. Harro J., Oreland L., Vasar E., Bradwejn J. Impaired exploratory behavior after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Eur. Neuropsychopharmacol. 5:1995;447-455
18. Harro J., Löfberg C., Rehfeld J.F., Oreland L. Cholecystokinin peptides and receptors in the rat brain during stress. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;59-66
19. Heffner T.G., Hartmann J.A., Seiden L.S. Feeding increases dopamine metabolism in the rat brain. Science. 208:1980;1168-1170
20. Hökfelt T., Skirboll J., Rehfeld J.F., Goldstein M., Markey K., Dann O. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing. Neuroscience. 5:1980;2093-2124
21. Ikemoto S., Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res. Rev. 31:1999;6-41
22. B receptors with amphetamine in responding for conditioned rewards. Peptides. 16:1995;959-964
23. A receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity. Psychopharmacology. 123:1996;131-143
24. A receptor involvement in the acquisition of conditioned activity by cocaine in rats. Brain Res. 763:1997;93-102
25. Kõks S., Volke V., Veraksits A., Rünkorg K., Sillat T., Abramov U., Bourin M., Huotari M., Männistö P.T., Matsui T., Vasar E. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system. Psychopharmacology (Berlin). 158:2001;198-204
26. Ladurelle N., Roques B.P., Dauge V. The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens. J. Neurosci. 15:1995;3118-3127
27. Marshall F.M., Barnes S., Hughes J., Woodruff G.N., Hunter J.C. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. J. Neurochem. 56:1991;917-922
28. Moran T.H., Schwartz G.J. Neurobiology of cholecystokinin. Crit. Rev. Neurobiol. 9:1994;1-28
29. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., Roques B.P. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 51:1999;745-781
30. Otter M.-H., Matto V., Sõukand R., Skrebuhhova T., Allikmets L., Harro J. Characterization of rat exploratory behavior using the exploration box test. Methods Find. Exp. Clin. Pharmacol. 19:1997;683-691
31. Pfaus J.G., Damsma G., Nomikos G.G., Wenkstern D.G., Blaka C.D., Phillips A.G., Fibiger H.C. Sexual behavior enhances central dopamine in the male rat. Brain Res. 530:1990;345-348
32. Philips G.D., Le Noury J., Wolterink G., Donselaar-Wolterink I., Robbins T.W., Everitt B.J. Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement. Behav. Brain Res. 55:1993;223-231
33. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:1997;192-216
34. Rebec G.V. Real-time assessments of dopamine function during behavior: single-unit recording, iontophoresis, and fast-scan cyclic voltammetry in awake, unrestrained rats. Alcohol Clin. Exp. Res. 22:1998;32-40
35. Rebec G.V., Grabner C.P., Johnson M., Pierce R.C., Bardo M.T. Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience. 76:1997;707-714
36. Segal D.S., Mandell A.J. Long-term administration of D-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2:1974;249-255
37. Shilling P.D., Feifel D. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI. Psychopharmacology. 164:2002;285-293
38. Tieppo C.A., Ferreira F.S., Sassatani A.S., Felicio L.F., Nasello A.G. Opposite modulation of apomorphine or amphetamine-induced stereotypy by antagonists of CCK receptors. Eur. J. Pharmacol. 387:2000;189-196
39. Vaccarino F.J., Rankin J. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity. Behav. Neurosci. 103:1989;831-836
40. Vasar E., Harro J., Lang A., Põld A., Soosaar A. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse. Psychopharmacology (Berlin). 105:1991;393-399
41. Wise R.A., Bozarth M.A. Brain mechanisms of drug reward and euphoria. Psychiatr. Med. 3:1985;445-460
42. Wunderlich G.R., DeSousa N.J., Vaccarino F.J. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat. Psychopharmacology (Berlin). 151:2000;283-290
43. Young A.M., Joseph M.H., Gray J.A. Increased dopamine release in vivo in nucleus accumbens and caudate nucleus of the rat during drinking: a microdialysis study. Neuroscience. 48:1992;871-876